• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超过 400 万退伍军人的血清胆固醇与年龄对冠心病死亡的影响。

Serum Cholesterol and Impact of Age on Coronary Heart Disease Death in More Than 4 Million Veterans.

机构信息

MAVERIC VA Boston Healthcare System Boston MA USA.

Carle Illinois College of Medicine University of Illinois Urbana Champaign Champaign IL USA.

出版信息

J Am Heart Assoc. 2023 Nov 7;12(21):e030496. doi: 10.1161/JAHA.123.030496. Epub 2023 Oct 27.

DOI:10.1161/JAHA.123.030496
PMID:37889207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10727410/
Abstract

Background The lipid hypothesis postulates that lower blood cholesterol is associated with reduced coronary heart disease (CHD) risk, which has been challenged by reports of a U-shaped relation between cholesterol and death in recent studies. We sought to examine whether the U-shaped relationship is true and to assess the impact of age on this association. Method and Results We conducted a prospective cohort study of 4 467 942 veterans aged >18 years, with baseline outpatient visits from 2002 to 2007 and follow-up to December 30, 2018, in the Veterans Health Administration electronic health record system. We observed a J-shaped relation between total cholesterol (TC) and CHD mortality after a comprehensive adjustment of confounding factors: flat for TC <180 mg/dL, and greater risk was present at higher cholesterol levels. Compared with veterans with TC between 180 and 199 mg/dL, the multiadjusted hazard ratios (HRs) for CHD death were 1.03 (95% CI, 1.02-1.04), 1.07 (95% CI, 1.06-1.09), 1.15 (95% CI, 1.13-1.18), 1.25 (95% CI, 1.22-1.28), and 1.45 (95% CI, 1.42-1.49) times greater among veterans with TC (mg/dL) of 200 to 219, 220 to 239, 140 to 259, 260 to 279 and ≥280, respectively. Similar J-shaped TC-CHD mortality patterns were observed among veterans with and without statin use at or before baseline. Conclusions The cholesterol paradox, for example, higher CHD death in patients with a low cholesterol level, was a reflection of reverse causality, especially among older participants. Our results support the lipid hypothesis that lower blood cholesterol is associated with reduced CHD. Furthermore, the hypothesis remained true when TC was low due to use of statins or other lipid-lowering medication.

摘要

背景

脂质假说认为,较低的血液胆固醇与降低冠心病(CHD)风险有关,但最近的研究报告显示胆固醇与死亡之间存在 U 形关系,这对该假说提出了挑战。我们试图研究这种 U 形关系是否真实,并评估年龄对这种关联的影响。

方法和结果

我们对 4467942 名年龄大于 18 岁的退伍军人进行了一项前瞻性队列研究,这些退伍军人在退伍军人健康管理局电子健康记录系统中有 2002 年至 2007 年的基线门诊就诊记录,并随访至 2018 年 12 月 30 日。在综合调整混杂因素后,我们观察到总胆固醇(TC)与 CHD 死亡率之间呈 J 形关系:TC<180mg/dL 时平坦,胆固醇水平较高时风险增加。与 TC 为 180 至 199mg/dL 的退伍军人相比,TC 为 200 至 219mg/dL、220 至 239mg/dL、140 至 259mg/dL、260 至 279mg/dL 和≥280mg/dL 的退伍军人的多因素校正后发生 CHD 死亡的危险比(HRs)分别为 1.03(95%CI,1.02-1.04)、1.07(95%CI,1.06-1.09)、1.15(95%CI,1.13-1.18)、1.25(95%CI,1.22-1.28)和 1.45(95%CI,1.42-1.49)倍;在有或无他汀类药物治疗的退伍军人中均观察到类似的 TC-CHD 死亡率 J 形模式。

结论

例如胆固醇悖论,即胆固醇水平较低的患者 CHD 死亡率较高,这反映了反向因果关系,尤其是在年龄较大的参与者中。我们的结果支持血液胆固醇较低与 CHD 风险降低相关的脂质假说。此外,当由于使用他汀类药物或其他降脂药物导致 TC 较低时,该假说仍然成立。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/10727410/04e46c1af716/JAH3-12-e030496-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/10727410/6d471fe5d9e2/JAH3-12-e030496-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/10727410/432a40c6e6a2/JAH3-12-e030496-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/10727410/68157718f5a2/JAH3-12-e030496-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/10727410/04e46c1af716/JAH3-12-e030496-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/10727410/6d471fe5d9e2/JAH3-12-e030496-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/10727410/432a40c6e6a2/JAH3-12-e030496-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/10727410/68157718f5a2/JAH3-12-e030496-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/10727410/04e46c1af716/JAH3-12-e030496-g003.jpg

相似文献

1
Serum Cholesterol and Impact of Age on Coronary Heart Disease Death in More Than 4 Million Veterans.超过 400 万退伍军人的血清胆固醇与年龄对冠心病死亡的影响。
J Am Heart Assoc. 2023 Nov 7;12(21):e030496. doi: 10.1161/JAHA.123.030496. Epub 2023 Oct 27.
2
Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.除了低密度脂蛋白胆固醇之外:非高密度脂蛋白胆固醇水平、甘油三酯以及总胆固醇/高密度脂蛋白胆固醇比值对貌似健康的男性和女性冠心病风险的各自影响。
J Am Coll Cardiol. 2009 Dec 29;55(1):35-41. doi: 10.1016/j.jacc.2009.07.057.
3
HDL cholesterol predicts coronary heart disease mortality in older persons.高密度脂蛋白胆固醇可预测老年人的冠心病死亡率。
JAMA. 1995 Aug 16;274(7):539-44.
4
Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men.孤立性低高密度脂蛋白胆固醇作为冠心病死亡的危险因素。对8000名男性进行的21年随访。
Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):107-13. doi: 10.1161/01.atv.17.1.107.
5
Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.在社区居住的老年人群体一级预防环境下,他汀类药物和贝特类药物治疗时,脂类和载脂蛋白能预测冠心病吗?3C 研究。
Atherosclerosis. 2011 Feb;214(2):426-31. doi: 10.1016/j.atherosclerosis.2010.10.040. Epub 2010 Nov 3.
6
A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.老年人血脂水平与冠心病的长期随访研究
Chin Med J (Engl). 2004 Feb;117(2):163-7.
7
[Need to change the direction of cholesterol-related medication--a problem of great urgency].[需要改变胆固醇相关药物的研发方向——一个迫在眉睫的问题]
Yakugaku Zasshi. 2005 Nov;125(11):833-52. doi: 10.1248/yakushi.125.833.
8
Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT).日本高胆固醇血症和冠心病患者血清胆固醇浓度与低剂量辛伐他汀治疗的冠状动脉事件之间关系的大规模队列研究:日本脂质干预试验(J-LIT)的二级预防队列研究
Circ J. 2002 Dec;66(12):1096-100. doi: 10.1253/circj.66.1096.
9
Lipid testing among patients beginning statin therapy in general practice in the United Kingdom.
Value Health. 2008 Sep-Oct;11(5):933-8. doi: 10.1111/j.1524-4733.2008.00345.x. Epub 2008 May 16.
10
The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.与冠心病相比,女性中C反应蛋白和血脂水平作为缺血性中风决定因素的相对强度。
J Am Coll Cardiol. 2006 Dec 5;48(11):2235-42. doi: 10.1016/j.jacc.2006.09.030. Epub 2006 Nov 13.

引用本文的文献

1
The Cholesterol Paradox in Long-Livers from a Sardinia Longevity Hot Spot (Blue Zone).来自撒丁岛长寿热点地区(蓝色区域)的长寿者中的胆固醇悖论。
Nutrients. 2025 Feb 21;17(5):765. doi: 10.3390/nu17050765.

本文引用的文献

1
Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey.根据2022年美国预防服务工作组(USPSTF)建议和2018年美国心脏协会(AHA)/美国心脏病学会(ACC)/多学会指南建议,比较他汀类药物用于一级预防的适用情况:来自美国国家健康与营养检查调查。
Prog Cardiovasc Dis. 2022 Nov-Dec;75:78-82. doi: 10.1016/j.pcad.2022.08.007. Epub 2022 Aug 28.
2
Association of Low-Density Lipoprotein Cholesterol Levels with More than 20-Year Risk of Cardiovascular and All-Cause Mortality in the General Population.低密度脂蛋白胆固醇水平与普通人群 20 多年心血管和全因死亡率的关系。
J Am Heart Assoc. 2022 Aug 2;11(15):e023690. doi: 10.1161/JAHA.121.023690. Epub 2022 Jul 29.
3
Non-HDL cholesterol paradox and effect of underlying malnutrition in patients with coronary artery disease: A 41,182 cohort study.非高密度脂蛋白胆固醇悖论及潜在营养不良对冠心病患者的影响:一项41,182例队列研究。
Clin Nutr. 2022 Mar;41(3):723-730. doi: 10.1016/j.clnu.2022.01.027. Epub 2022 Feb 6.
4
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target.载脂蛋白B与心血管疾病:生物标志物及潜在治疗靶点
Metabolites. 2021 Oct 8;11(10):690. doi: 10.3390/metabo11100690.
5
Lipoprotein(a) and Cardiovascular Disease.脂蛋白(a)与心血管疾病。
Clin Chem. 2021 Jan 8;67(1):154-166. doi: 10.1093/clinchem/hvaa247.
6
Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.他汀类药物使用与美国 75 岁及以上退伍军人全因和心血管死亡率的关系。
JAMA. 2020 Jul 7;324(1):68-78. doi: 10.1001/jama.2020.7848.
7
Total cholesterol and all-cause mortality by sex and age: a prospective cohort study among 12.8 million adults.按性别和年龄划分的总胆固醇与全因死亡率:一项针对 1280 万成年人的前瞻性队列研究。
Sci Rep. 2019 Feb 7;9(1):1596. doi: 10.1038/s41598-018-38461-y.
8
Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis.降脂治疗后 LDL-C 水平与全因及心血管死亡率的相关性:系统评价和荟萃分析。
JAMA. 2018 Apr 17;319(15):1566-1579. doi: 10.1001/jama.2018.2525.
9
Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study.血清总胆固醇与老年人心血管和非心血管死亡率的风险:一项基于人群的研究。
BMC Geriatr. 2017 Dec 28;17(1):294. doi: 10.1186/s12877-017-0685-z.
10
Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial.他汀类药物治疗与常规治疗对老年人原发性心血管预防的影响:ALLHAT-LLT随机临床试验
JAMA Intern Med. 2017 Jul 1;177(7):955-965. doi: 10.1001/jamainternmed.2017.1442.